Evidence map›Paper›PMID 41899279›Full record

ArticleJournal of clinical medicine2026

Associations of Tumor Somatic Mutations and Genetic Alterations with Survival Outcomes in Melanoma Patients Treated with Ipilimumab.

Mohammad Ali Khaksar, Islam Eljilany, Ibrahim Yassine, Xiaoqing Yu, Jamie K Teer, Jose R Conejo-Garcia, Maureen Lyons, William LaFramboise, Ahmad A Tarhini

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohammad Ali KhaksarDepartments of Cutaneous Oncology and Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.ORCID 0000-0002-2545-1436
Islam EljilanyDepartments of Cutaneous Oncology and Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.ORCID 0000-0001-6387-5419
Ibrahim YassineFaculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.
Xiaoqing YuDepartment of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Jamie K TeerDepartment of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.ORCID 0000-0003-4513-0282
Jose R Conejo-GarciaDepartment of Integrative Immunobiology, Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0001-6431-4074
Maureen LyonsCancer Genomics Facility, University of Pittsburgh, Pittsburgh, PA 15260, USA.
William LaFramboiseMolecular Diagnostics Laboratory, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15212, USA.ORCID 0000-0002-6024-810X
Ahmad A TarhiniDepartments of Cutaneous Oncology and Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

Funding

Bristol Myers Squibb CA184-082Moffitt Cancer Center P30CA016056
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CTLA-4 blockadeimmune checkpoint inhibitoripilimumabmelanomaneoadjuvantsomatic mutationsurvival outcomestumor mutational burden

Identifiers

PMID41899279
PMCPMC13026618

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.